Yestar Healthcare Holdings Company Limited (stock code: 02393) published its monthly return for the period ended 28 February 2026. The company’s authorized share capital remained at 4,000,000,000 ordinary shares, each with a par value of HKD 0.03, totaling HKD 100.00 million.
The number of issued shares stood at 2,331.59 million, with no treasury shares recorded. The company confirmed that its public float requirement of 25.00% had been satisfied as of the end of February 2026. No new share options, warrants, or convertible instruments were reported.
According to the submission dated 02 March 2026, all requisite approvals and regulatory requirements for any securities-related movements during the month have been met. No changes to the overall share structure were disclosed in the announcement.